Follow
Yuyu He
Title
Cited by
Cited by
Year
The prognostic value of autophagy-related markers beclin-1 and microtubule-associated protein light chain 3B in cancers: a systematic review and meta-analysis
Y He, X Zhao, NR Subahan, L Fan, J Gao, H Chen
Tumor Biology 35, 7317-7326, 2014
812014
Caveolin-1 expression level in cancer associated fibroblasts predicts outcome in gastric cancer
X Zhao, Y He, J Gao, L Fan, Z Li, G Yang, H Chen
PLoS One 8 (3), e59102, 2013
802013
Inhibiting tumor necrosis factor-alpha diminishes desmoplasia and inflammation to overcome chemoresistance in pancreatic ductal adenocarcinoma
X Zhao, W Fan, Z Xu, H Chen, Y He, G Yang, G Yang, H Hu, S Tang, ...
Oncotarget 7 (49), 81110, 2016
782016
Comparison of frame-based versus frameless intracranial stereotactic biopsy: systematic review and meta-analysis
S Dhawan, Y He, J Bartek Jr, AA Alattar, CC Chen
World neurosurgery 127, 607-616. e4, 2019
772019
Autophagic tumor stroma: mechanisms and roles in tumor growth and progression
X Zhao, Y He, H Chen
International journal of cancer 132 (1), 1-8, 2013
552013
Quantum dots-based immunofluorescent imaging of stromal fibroblasts Caveolin-1 and light chain 3B expression and identification of their clinical significance in human gastric …
Y He, X Zhao, J Gao, L Fan, G Yang, WC Cho, H Chen
International journal of molecular sciences 13 (11), 13764-13780, 2012
402012
High expression of Bcl-2 protein predicts favorable outcome in non-small cell lung cancer: evidence from a systematic review and meta-analysis
XD Zhao, YY He, J Gao, C Zhao, LL Zhang, JY Tian, HL Chen
Asian Pacific Journal of Cancer Prevention 15 (20), 8861-8869, 2014
212014
Epidermal growth factor receptor as a molecular determinant of glioblastoma response to dopamine receptor D2 inhibitors
Y He, J Li, T Koga, J Ma, S Dhawan, Y Suzuki, F Furnari, VV Prabhu, ...
Neuro-oncology 23 (3), 400-411, 2021
172021
美国的医学生科研能力培养对我国的启示
范静怡, 何禹禹, 赵显达, 陈洪雷
中国成人教育, 108-111, 2013
142013
武汉市民对临终关怀知晓率和态度的调查
赵显达, 吴新, 刘东瀛, 何禹禹
首都医科大学学报 32 (2), 297, 2011
102011
Gene expression and mutational profile in BAP-1 inactivated melanocytic lesions of progressive malignancy from a patient with multiple lesions
Y Zhou, AC Nelson, Y He, SA Munro, KY Song, E Domingo-Musibay, ...
Genes 13 (1), 10, 2021
42021
Receptor for hyaluronan‐mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients
SE Tarullo, Y He, C Daughters, TP Knutson, CM Henzler, MA Price, ...
The Journal of pathology 260 (3), 289-303, 2023
32023
Molecular characterization of biphenotypic epithelioid and plexiform melanoma with deep penetrating nevus‐like features
A Giubellino, AC Nelson, Y He, SA Munro, KY Song, IC Glitza Oliva, ...
Pigment Cell & Melanoma Research 35 (2), 229-237, 2022
22022
Immunohistochemistry screening for TP53 mutation in myeloid neoplasms in AZF-fixed bone marrow biopsies
G Yang, SA Williams, F He, Y He, K McIntyre, AK Beckman, AC Nelson, ...
Pathology, 2024
2024
Gene Expression and Mutational Profile in BAP-1 Inactivated Melanocytic Lesions of Progressive Malignancy from a Patient with Multiple Lesions. Genes 2022, 13, 10
Y Zhou, AC Nelson, Y He, SA Munro, KY Song, E Domingo-Musibay, ...
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021
2021
Epidermal growth factor receptor expression as a molecular determinant of glioblastoma response to the dopamine receptor D2 antagonist, ONC201.
Y He, J Ma, S Dhawan, T Koga, F Furnari, VV Prabhu, JE Allen, CC Chen
Journal of Clinical Oncology 38 (15_suppl), e14552-e14552, 2020
2020
A Pipeline Approach in Identifying Important Input Features from Neural Networks
ZL Yuyu He, Chih Lai, Dalma Martinović-Weigelt
2019 14th Annual Conference System of Systems Engineering (SoSE), 2019
2019
EXTH-26. MOLECULAR DETERMINANT OF CLINICAL RESPONSE TO ONC201, AN INHIBITOR OF DOPAMINE RECEPTOR 2 (DRD2) SIGNALING, IN GLIOBLASTOMA PATIENT
J Li, J Ma, Y He, VV Prabhu, J Allen, C Chen
Neuro-oncology 20 (Suppl 6), vi90, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–18